Skip to main navigation Skip to search Skip to main content

775 Initial results from dose escalation of a phase 1/2 first-in-human, open label study of AU-007, a monoclonal antibody that binds to IL-2 and prevents its binding to CD25, in patients with solid tumors

  • James Vasselli
  • , Paul de Souza
  • , Sophia Frentzas
  • , Andrew Weickhardt
  • , Timothy Wyant
  • , Jenny Tang
  • , Lori Richards
  • , Aron Knickerbocker
  • , Inbar Amit
  • , Yanay Ofran

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of '775 Initial results from dose escalation of a phase 1/2 first-in-human, open label study of AU-007, a monoclonal antibody that binds to IL-2 and prevents its binding to CD25, in patients with solid tumors'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Immunology and Microbiology

Keyphrases